Cargando…

Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer

BACKGROUND: Bleeding from the pulmonary artery (PA) can be fatal in video‐assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection. METHODS: We retrospectively analyzed a total of 1098 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomoyasu, Makoto, Deguchi, Hiroyuki, Kudo, Satoshi, Shigeeda, Wataru, Kaneko, Yuka, Yoshimura, Ryuichi, Kanno, Hironaga, Saito, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626345/
https://www.ncbi.nlm.nih.gov/pubmed/36114752
http://dx.doi.org/10.1111/1759-7714.14649
_version_ 1784822710905339904
author Tomoyasu, Makoto
Deguchi, Hiroyuki
Kudo, Satoshi
Shigeeda, Wataru
Kaneko, Yuka
Yoshimura, Ryuichi
Kanno, Hironaga
Saito, Hajime
author_facet Tomoyasu, Makoto
Deguchi, Hiroyuki
Kudo, Satoshi
Shigeeda, Wataru
Kaneko, Yuka
Yoshimura, Ryuichi
Kanno, Hironaga
Saito, Hajime
author_sort Tomoyasu, Makoto
collection PubMed
description BACKGROUND: Bleeding from the pulmonary artery (PA) can be fatal in video‐assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection. METHODS: We retrospectively analyzed a total of 1098 patients who underwent radical surgery for lung cancer utilizing complete VATS from January 2010 to December 2021. RESULTS: A total of 16 patients (1.5%) had PA injury during VATS, while hemostasis was performed by conversion to thoracotomy in eight patients (50.0%). Although there was a significantly greater operation time and blood loss for patients in the PA injury group (318.4 vs. 264.9 min, p = 0.001; 550.3 vs. 60.5 g, p ≤ 0.001, respectively), there was no significant different for the chest tube insertion duration and length of postoperative hospital stay (4.9 vs. 7.8 days, p = 0.157; 10.6 vs. 9.9 days, p = 0.136, respectively). There was a significant difference observed for the surgical procedure related to the left upper lobectomy in the PA injury group (43.8 vs. 18.8%, p = 0.012), with the primary causative PA determined to be the left anterior segmental PA (A(3)) (31.3%). CONCLUSIONS: VATS is both feasible and safe for lung cancer treatment provided the surgeon performs appropriate hemostasis, although fatal vascular injury could potentially occur during VATS. Surgeons need to be aware of the pitfalls regarding PA dissection management.
format Online
Article
Text
id pubmed-9626345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-96263452022-11-03 Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer Tomoyasu, Makoto Deguchi, Hiroyuki Kudo, Satoshi Shigeeda, Wataru Kaneko, Yuka Yoshimura, Ryuichi Kanno, Hironaga Saito, Hajime Thorac Cancer Original Articles BACKGROUND: Bleeding from the pulmonary artery (PA) can be fatal in video‐assisted thoracoscopic surgery (VATS) for lung cancer. We evaluated intraoperative PA injury and assessed precautions for thoracoscopic anatomic pulmonary resection. METHODS: We retrospectively analyzed a total of 1098 patients who underwent radical surgery for lung cancer utilizing complete VATS from January 2010 to December 2021. RESULTS: A total of 16 patients (1.5%) had PA injury during VATS, while hemostasis was performed by conversion to thoracotomy in eight patients (50.0%). Although there was a significantly greater operation time and blood loss for patients in the PA injury group (318.4 vs. 264.9 min, p = 0.001; 550.3 vs. 60.5 g, p ≤ 0.001, respectively), there was no significant different for the chest tube insertion duration and length of postoperative hospital stay (4.9 vs. 7.8 days, p = 0.157; 10.6 vs. 9.9 days, p = 0.136, respectively). There was a significant difference observed for the surgical procedure related to the left upper lobectomy in the PA injury group (43.8 vs. 18.8%, p = 0.012), with the primary causative PA determined to be the left anterior segmental PA (A(3)) (31.3%). CONCLUSIONS: VATS is both feasible and safe for lung cancer treatment provided the surgeon performs appropriate hemostasis, although fatal vascular injury could potentially occur during VATS. Surgeons need to be aware of the pitfalls regarding PA dissection management. John Wiley & Sons Australia, Ltd 2022-09-17 2022-11 /pmc/articles/PMC9626345/ /pubmed/36114752 http://dx.doi.org/10.1111/1759-7714.14649 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Tomoyasu, Makoto
Deguchi, Hiroyuki
Kudo, Satoshi
Shigeeda, Wataru
Kaneko, Yuka
Yoshimura, Ryuichi
Kanno, Hironaga
Saito, Hajime
Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title_full Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title_fullStr Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title_full_unstemmed Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title_short Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
title_sort evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626345/
https://www.ncbi.nlm.nih.gov/pubmed/36114752
http://dx.doi.org/10.1111/1759-7714.14649
work_keys_str_mv AT tomoyasumakoto evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT deguchihiroyuki evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT kudosatoshi evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT shigeedawataru evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT kanekoyuka evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT yoshimuraryuichi evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT kannohironaga evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer
AT saitohajime evaluationofpulmonaryarterybleedingduringthoracoscopicpulmonaryresectionforlungcancer